SHAREHOPE MEDICINE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.85 TWD | -0.78% |
|
-0.62% | -3.19% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 4.14B 128M | Sales 2023 | 3.87B 120M | Capitalization | 4.15B 128M |
|---|---|---|---|---|---|
| Net income 2022 | 294M 9.08M | Net income 2023 | 125M 3.86M | EV / Sales 2022 | 1.09 x |
| Net Debt 2022 | 460M 14.2M | Net Debt 2023 | 787M 24.28M | EV / Sales 2023 | 1.27 x |
| P/E ratio 2022 |
13.9
x | P/E ratio 2023 |
33.6
x | Employees | - |
| Yield 2022 |
1.48% | Yield 2023 |
-
| Free-Float | 64.37% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.31% | ||
| 1 week | +0.16% | ||
| Current month | +0.16% | ||
| 1 month | +2.23% | ||
| 3 months | +0.63% | ||
| 6 months | -3.31% | ||
| Current year | -2.43% |
1 week
31.80
33.00
1 month
30.5033.00
Current year
30.5033.95
1 year
30.5042.48
3 years
23.0444.10
5 years
19.8445.36
10 years
19.6645.36
| Managers | Title | Age | Since |
|---|---|---|---|
Hung Jen Yang
CEO | Chief Executive Officer | 55 | 03-11-03 |
Ching Wen Liu
BRD | Director/Board Member | - | 05-05-31 |
Wei Kuang Ho
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ching Wen Liu
BRD | Director/Board Member | - | 05-05-31 |
| Director/Board Member | - | 03-09-09 | |
Sheng Hsin Hsu
BRD | Director/Board Member | - | 03-09-09 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 31.85 | -0.78% | 129 621 |
| 24-05-08 | 32.1 | +0.31% | 141,665 |
| 24-05-07 | 32 | -0.47% | 207,792 |
| 24-05-06 | 32.15 | -0.46% | 161,201 |
| 24-05-03 | 32.3 | -1.52% | 316,803 |
End-of-day quote Taipei Exchange, May 07, 2024
More quotes
ShareHope Medicine Co., Ltd. is principally engaged in the supply of pharmaceuticals, medical materials and technology materials. The Company is also engaged in the provision of medical health check and medical testing laboratories management consulting and entrusted operation services, the leasing of equipment and the provision of long-term care services. The Company operates its business through five segments: pharmaceutical distribution, health management, technology materials, hospitals and others. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -2.43% | 125M | |
| -2.25% | 23.73B | |
| +1.47% | 8.28B | |
| +7.71% | 8.26B | |
| -19.61% | 8.07B | |
| +5.56% | 4.8B | |
| +15.41% | 4.26B | |
| -0.87% | 4.08B | |
| -1.86% | 3.92B | |
| +23.20% | 3.68B |
- Stock Market
- Equities
- 8403 Stock